Latest Insider Transactions at American Equity Investment Life Holding CO (AEL-PA)
This section provides a real-time view of insider transactions for American Equity Investment Life Holding CO (AEL-PA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMERICAN EQUITY INVESTMENT LIFE HOLDING CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMERICAN EQUITY INVESTMENT LIFE HOLDING CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2023
|
Dewayne Lummus SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,859
+16.9%
|
-
|
|
Feb 23
2023
|
Kate Etinger EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,169
+50.0%
|
-
|
|
Feb 23
2023
|
Axel Andre EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,231
+34.48%
|
-
|
|
Feb 23
2023
|
Anant Bhalla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
26,512
+2.24%
|
-
|
|
Feb 23
2023
|
Nicholas P. Volpe EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,928
+12.15%
|
-
|
|
Feb 23
2023
|
James Louis Hamalainen EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,231
+17.91%
|
-
|
|
Feb 23
2023
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,061
+7.19%
|
-
|
|
Feb 01
2023
|
Anant Bhalla CEO & President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
91,000
-7.45%
|
$4,095,000
$45.0 P/Share
|
|
Feb 01
2023
|
Anant Bhalla CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
75,667
-5.84%
|
$3,405,015
$45.0 P/Share
|
|
Nov 30
2022
|
Dewayne Lummus SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,405
-11.15%
|
$56,200
$40.51 P/Share
|
|
Nov 29
2022
|
Anant Bhalla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+48.07%
|
-
|
|
Aug 09
2022
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
25,000
-40.69%
|
$1,000,000
$40.0 P/Share
|
|
Aug 01
2022
|
Nicholas P. Volpe EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+50.0%
|
-
|
|
Jun 15
2022
|
End Re (Cayman) Spc North |
SELL
Other acquisition or disposition
|
Direct |
3,857,184
-24.28%
|
$150,430,176
$39.18 P/Share
|
|
Jun 10
2022
|
David S. Mulcahy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+2.8%
|
-
|
|
Jun 10
2022
|
Robert L Howe Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+4.07%
|
-
|
|
Jun 10
2022
|
Gerard D. Neugent Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+6.19%
|
-
|
|
Jun 10
2022
|
William R. Kunkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+10.6%
|
-
|
|
Jun 10
2022
|
Alan David Matula Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+9.88%
|
-
|
|
Jun 10
2022
|
Joyce Ann Chapman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+6.16%
|
-
|
|
Jun 10
2022
|
Brenda J Cushing Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+15.51%
|
-
|
|
Jun 10
2022
|
Douglas Taylor Healy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,601
+26.93%
|
-
|
|
May 16
2022
|
Gerard D. Neugent Director |
SELL
Open market or private sale
|
Direct |
4,237
-3.86%
|
$148,295
$35.07 P/Share
|
|
May 16
2022
|
Gerard D. Neugent Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+20.22%
|
$140,000
$10.52 P/Share
|
|
May 11
2022
|
Robert L Howe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+9.96%
|
$90,000
$10.52 P/Share
|
|
Apr 12
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Open market or private sale
|
Direct |
9,188
-9.35%
|
$349,144
$38.31 P/Share
|
|
Mar 15
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Open market or private sale
|
Direct |
12,844
-11.41%
|
$488,072
$38.06 P/Share
|
|
Mar 14
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,963
-12.42%
|
$606,594
$38.37 P/Share
|
|
Mar 09
2022
|
Joyce Ann Chapman Director |
SELL
Open market or private sale
|
Direct |
3,856
-6.99%
|
$146,528
$38.26 P/Share
|
|
Mar 09
2022
|
Joyce Ann Chapman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+20.25%
|
$140,000
$10.52 P/Share
|
|
Mar 02
2022
|
Robert L Howe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.46%
|
$50,000
$10.52 P/Share
|
|
Feb 28
2022
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,692
-12.07%
|
$321,604
$37.69 P/Share
|
|
Feb 28
2022
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,175
+21.02%
|
-
|
|
Feb 28
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,414
-6.83%
|
$348,318
$37.69 P/Share
|
|
Feb 28
2022
|
Ronald James Grensteiner Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
22,014
+13.77%
|
-
|
|
Feb 23
2022
|
James Louis Hamalainen EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,370
+17.17%
|
-
|
|
Feb 23
2022
|
Axel Andre EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,509
+50.0%
|
-
|
|
Feb 23
2022
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,445
+6.12%
|
-
|
|
Feb 23
2022
|
Dewayne Lummus SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,085
+19.67%
|
-
|
|
Feb 23
2022
|
Ronald James Grensteiner Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,390
+2.84%
|
-
|
|
Feb 23
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,894
-8.83%
|
$392,184
$36.03 P/Share
|
|
Feb 23
2022
|
Phyllis Joy Zanghi EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
3,255
+39.48%
|
-
|
|
Feb 23
2022
|
Anant Bhalla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
24,410
+20.21%
|
-
|
|
Jan 27
2022
|
Anant Bhalla CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-5.67%
|
$168,675
$39.89 P/Share
|
|
Jan 20
2022
|
Ronald James Grensteiner Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,894
-7.84%
|
$457,548
$42.05 P/Share
|
|
Jan 07
2022
|
Jeffrey D Lorenzen EVP & Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
20,000
-15.57%
|
$820,000
$41.09 P/Share
|
|
Nov 30
2021
|
Dewayne Lummus SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,515
+50.0%
|
-
|
|
Nov 30
2021
|
Anant Bhalla CEO & President |
SELL
Open market or private sale
|
Direct |
5,714
-100.0%
|
$148,564
$26.8 P/Share
|
|
Nov 30
2021
|
Anant Bhalla CEO & President |
SELL
Open market or private sale
|
Direct |
4,500
-5.57%
|
$148,500
$33.25 P/Share
|
|
Nov 30
2021
|
Anant Bhalla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+8.5%
|
$247,500
$33.25 P/Share
|